Tuesday 17 November 2026
Export BRVE’s income statement to Excel — free account
Braveheart Bio, Inc.
BRVE- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
19.38
0.24
−1.22%
Follow BRVE
Alert me
Where the cash went Q3 FY2026, quarter to 30 September 2026
Free cash flow was −$24.4M: capital expenditures were more than operating cash flow. Cash fell by $1.5M. Lines the picture does not name came to −$386.2M. What is a cash flow statement?
- Free cash flow
- −$24.4M
- Returned to shareholders
- $0.00
- Debt, net
- $0.00 borrowed
- Change in cash
- −$1.5M over the period
| Operating cash flow | 0.0 |
|---|---|
| Free cash flow | 0.0 |
| Shares issued, net | +0.4 |
| Other | −0.4 |
| Change in cash | 0.0 |
| Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|
| Operating cash flow | $0.0B | $0.0B | $0.0B |
| Capex | $0.0B | $0.0B | $0.0B |
| Free cash flow | $0.0B | $0.0B | $0.0B |
Figures in billions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Net Income |
+3 more quarters Free account |
(6.45) | (14.28) | (14.99) | (26.49) |
Depreciation & Amortization |
— | 0.00 | 0.00 | 0.00 | |
Non Cash Items (Other) |
— | 1.76 | 1.09 | 8.44 | |
Accounts Payable Change |
— | 6.88 | (5.94) | 0.13 | |
Change in payables and accrued liability |
— | 0.91 | 3.01 | 3.20 | |
Change in other assets and liabilities |
— | (0.45) | (0.12) | (9.65) | |
Operating Cash Flow |
(1.27) | (5.19) | (16.95) | (24.37) | |
Capital expenditures |
— | (0.04) | 0.01 | 0.00 | |
Other investing activities |
(0.83) | (3.00) | 0.00 | 0.00 | |
Investing cash flow |
(0.83) | (3.04) | 0.01 | (382.45) | |
Equity Repurchase (Preffered, Net) |
— | (0.36) | 59.96 | (0.01) | |
Other financial activities |
— | — | — | (3.78) | |
Financing cash flow |
23.74 | (0.36) | 59.20 | 405.28 | |
Change in Cash |
21.63 | (8.58) | 42.26 | (1.54) | |
Beginning Cash |
— | 89.16 | 0.00 | 0.00 | |
Ending Cash |
21.63 | 80.58 | 42.26 | (1.54) | |
Stock Based Compensation |
— | 1.76 | 1.09 | 8.94 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
1.98 | 7.33 | (3.05) | (6.32) | |
Issuance/Purchase of Shares |
23.74 | (0.36) | 59.96 | 409.06 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 12 Nov 2026